Financhill
Back

SELLAS Life Sciences Group Stock Predictions

SELLAS Life Sciences Group Stock Forecast

  • Is SELLAS Life Sciences Group Stock Undervalued?
    The current SELLAS Life Sciences Group [SLS] share price is $0.90. The Score for SLS is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • SLS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will SELLAS Life Sciences Group Stock Go Up Next Year?

Data Unavailable

SELLAS Life Sciences Group Stock Rating

Data Unavailable

SELLAS Life Sciences Group Stock Price History

Is SLS stock going to rise?

  • The current trend is relatively stagnant and SLS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sellaslifesciences.com

52-Week Data

52-Week High:
1.72
52-Week Low:
0.50

Prediction Charts

Market Cap:
63.4M
Price in USD:
0.90
Volume:
1.1M
Beta:
1.45

Technical Analysis

SMA50:
1.15
SMA100:
1.20
SMA200:
1.24
52-Wk Change:
-26.18%

Stock Predictions

  • Is SELLAS Life Sciences Group stock public?
    Yes, SELLAS Life Sciences Group is a publicly traded company.
  • What is the SELLAS Life Sciences Group stock quote today?
    The SELLAS Life Sciences Group stock price is 0.90 USD today.
  • How to buy SELLAS Life Sciences Group stock online?
    You can buy SELLAS Life Sciences Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 1.22 1.18 1.23 1.15
Dec-4 1.22 1.11 1.22 1.07
Dec-5 1.10 1.10 1.14 1.05
Dec-6 1.11 1.14 1.19 1.08
Dec-9 1.10 1.09 1.14 1.06
Dec-10 1.13 1.04 1.16 0.98
Dec-11 1.01 0.90 1.05 0.87
Dec-12 0.90 0.86 0.95 0.83
Dec-13 0.86 0.87 0.89 0.77
Dec-16 0.90 0.92 0.98 0.87
Dec-17 0.95 0.88 0.96 0.86
Dec-18 0.89 0.86 0.92 0.84
Dec-19 0.83 0.90 0.92 0.83
Dec-20 0.91 0.90 0.93 0.87

SELLAS Life Sciences Group Earnings

Data Unavailable

SELLAS Life Sciences Group Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.07 per share.

* SELLAS Life Sciences Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.